Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Greenwich LifeSciences Inc: Is Infosys Ltd. worth buying?
Item: Greenwich LifeSciences Inc
Rating: 1.25283325
Author: Trendlyne DVM scores

about

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

11.67 -0.26 (-2.18%)

29.27% Fall from 52W High

15,585

XNAS Volume

XNAS 27 Aug, 2025 4:19 PM (EDT)

Not Eligible

Expensive Valuation

0.3 / 100

Technically Neutral

49.8 / 100

No estimates available

Greenwich LifeSciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

29.27% Fall from 52W High

SWOT Analysis

Greenwich LifeSciences Inc Live Price Chart